Literature DB >> 21488158

A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size.

Payal D Patel1, Joy M Samanich, William B Mitchell, Deepa Manwani.   

Abstract

Wiskott-Aldrich Syndrome (WAS) is a triad of immunodeficiency, eczema, and thrombocytopenia. Despite the heterogeneity of genetic and clinical findings, a correlation with small platelet size is routinely observed. Herein we describe a case with a unique phenotype that links normal mean platelet volume with the classic characteristics of this disease. The diagnosis was verified by genetic analysis showing a novel and de novo mutation. Our case illustrates that a high index of suspicion of WAS is warranted even in the setting of normal sized platelets.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488158     DOI: 10.1002/pbc.22920

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

Review 1.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

2.  Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott-Aldrich Syndrome.

Authors:  Robert Sokolic; Neal Oden; Fabio Candotti
Journal:  Front Pediatr       Date:  2015-06-01       Impact factor: 3.418

Review 3.  Refractory thrombocytopenia and neutropenia: a diagnostic challenge.

Authors:  Emmanuel Gyan; François Dreyfus; Pierre Fenaux
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-02-18       Impact factor: 2.576

4.  A rare case of Wiskott-Aldrich Syndrome with normal platelet size: a case report.

Authors:  Mohd Farid Baharin; Jasbir Singh Dhaliwal; Smrdhi V V Sarachandran; Siti Zaharah Idris; Seoh Leng Yeoh
Journal:  J Med Case Rep       Date:  2016-06-29

5.  Intermittent low platelet counts hampering diagnosis of X-linked thrombocytopenia in children: report of two unrelated cases and a novel mutation in the gene coding for the Wiskott-Aldrich syndrome protein.

Authors:  Samuel Souza Medina; Lúcia Helena Siqueira; Marina Pereira Colella; Gabriela Goes Yamaguti-Hayakawa; Bruno Kosa Lino Duarte; Maria Marluce Dos Santos Vilela; Margareth Castro Ozelo
Journal:  BMC Pediatr       Date:  2017-06-22       Impact factor: 2.125

6.  Identification of a novel WAS mutation in a South African patient presenting with atypical Wiskott-Aldrich syndrome: a case report.

Authors:  Brigitte Glanzmann; Marlo Möller; Mardelle Schoeman; Michael Urban; Paul D van Helden; Lisa Frigati; Ravnit Grewal; Hermanus Pieters; Ben Loos; Eileen G Hoal; Richard H Glashoff; Helena Cornelissen; Helena Rabie; Monika M Esser; Craig J Kinnear
Journal:  BMC Med Genet       Date:  2020-06-05       Impact factor: 2.103

Review 7.  Clinical Features, Cancer Biology, Transplant Approach and Other Integrated Management Strategies for Wiskott-Aldrich Syndrome.

Authors:  Smitha Hosahalli Vasanna; Maria A Pereda; Jignesh Dalal
Journal:  J Multidiscip Healthc       Date:  2021-12-23

Review 8.  Management of thrombocytopenia.

Authors:  Marina Izak; James B Bussel
Journal:  F1000Prime Rep       Date:  2014-06-02

Review 9.  A Review on Secondary Immune Thrombocytopenia in Malaysia.

Authors:  Muhamad Aidil Zahidin; Noor Haslina Mohd Noor; Muhammad Farid Johan; Abu Dzarr Abdullah; Zefarina Zulkafli; Hisham Atan Edinur
Journal:  Healthcare (Basel)       Date:  2021-12-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.